Optiray 350 and Depression aggravated - a phase IV clinical study of FDA data

Summary:

Depression aggravated is reported as a side effect among people who take Optiray 350 (ioversol), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Trasylol, and have Acne cystic.

The phase IV clinical study analyzes which people have Depression aggravated when taking Optiray 350. It is created by eHealthMe based on reports of 1,522 people who have side effects when taking Optiray 350 from the FDA, and is updated regularly.

What is Optiray 350?

Optiray 350 has active ingredients of ioversol. eHealthMe is studying from 1,523 Optiray 350 users. Check the latest studies of Optiray 350.

What is Depression aggravated?

Depression aggravated is found to be associated with 2,366 drugs and 748 conditions by eHealthMe. Check the latest studies of Depression aggravated.

On Jul, 12, 2026

1,522 people reported to have side effects when taking Optiray 350.
Among them, 15 people (0.99%) have Depression aggravated.

Could Optiray 350 cause Depression aggravated?

Among these 15 people:

How long have people been on Optiray 350 when they have Depression aggravated? *

What is the gender of people who have Depression aggravated when taking Optiray 350? *

female: 73.33 %
male: 26.67 %

What is the age of people who have Depression aggravated when taking Optiray 350? *

What are other drugs people take besides Optiray 350? *

What are other side effects people have besides Depression aggravated? *

Injury: 14 people, 93.33%
Stress And Anxiety: 14 people, 93.33%
Acute Kidney Failure: 14 people, 93.33%
Pain: 13 people, 86.67%
Fear: 13 people, 86.67%
Anhedonia (inability to experience pleasure from activities usually found enjoyable): 12 people, 80.00%
Emotional Distress: 7 people, 46.67%
Renal Injury (kidney injury): 7 people, 46.67%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 5 people, 33.33%
Multi-Organ Failure (multisystem organ failure): 4 people, 26.67%

What are the existing conditions these people have? *

Thyroid Diseases: 1 person, 6.67%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 6.67%
High Blood Pressure: 1 person, 6.67%
High Blood Cholesterol: 1 person, 6.67%
Fluid Retention (an abnormal accumulation of fluid in the blood): 1 person, 6.67%
Chest Pain: 1 person, 6.67%
Acne Cystic (skin problems that cause pimples): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Optiray 350 and have Depression aggravated?

- Check whether Depression aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Optiray 350:

Optiray 350 (1,523 reports)

Browse all side effects of Optiray 350:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Depression aggravated:

Depression aggravated (2,367 drugs)

Browse all the conditions that are associated with Depression aggravated:

Depression aggravated (748 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ioversol (the active ingredients of Optiray 350) and Optiray 350 (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.